Disciplined Investments’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-607
Closed -$53.5K 959
2023
Q2
$53.5K Buy
607
+21
+4% +$1.81K 0.03% 193
2023
Q1
$47.2K Buy
586
+12
+2% +$978 0.02% 229
2022
Q4
$44.6K Sell
574
-9
-2% -$729 0.02% 214
2022
Q3
$47K Sell
583
-6
-1% -$539 0.02% 228
2022
Q2
$53K Sell
589
-10
-2% -$1.01K 0.02% 213
2022
Q1
$66K Buy
599
+167
+39% +$17.6K 0.03% 198
2021
Q4
$45K Hold
432
0.02% 218
2021
Q3
$54K Hold
432
0.03% 196
2021
Q2
$54K Hold
432
0.03% 193
2021
Q1
$51K Hold
432
0.03% 179
2020
Q4
$51K Hold
432
0.03% 152
2020
Q3
$45K Sell
432
-168
-28% -$16.9K 0.03% 168
2020
Q2
$55K Hold
600
0.04% 154
2020
Q1
$54K Hold
600
0.05% 146
2019
Q4
$68K Buy
+600
New +$65.8K 0.06% 143

Other funds holding MDT

Disciplined Investments's MDT Position: Q3 2023 in Review

Disciplined Investments sold out of Medtronic (MDT) in Q3 2023, closing a stake of 607 shares — an estimated $53.5K sold.

Disciplined Investments first reported a position in MDT in Q4 2019 and held it in 15 quarters. The position peaked at $68K in Q4 2019. 1,971 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

  • Disciplined Investments reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
  • Disciplined Investments sold 607 Medtronic shares in Q3 2023, an estimated $53.5K.
  • Disciplined Investments first reported a position in Medtronic in Q4 2019 and held it in 15 quarters.
  • Disciplined Investments's Medtronic position peaked at $68K in Q4 2019.
  • 1,971 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on Disciplined Investments's 13F filing for Q3 2023, filed 14 Nov 2023.